Zobrazeno 1 - 3
of 3
pro vyhledávání: '"D B, Bresnahan"'
Autor:
D B, Bresnahan, G N, Pandey, P G, Janicak, R, Sharma, R A, Boshes, S S, Chang, B L, Gierl, J M, Davis
Publikováno v:
The Journal of clinical psychiatry. 51(2)
The authors studied clinical response in 47 depressed inpatients treated with the monoamine oxidase (MAO) inhibitor phenelzine. Improvement on ratings for depression at Week 2 of treatment was correlated with percent MAO inhibition at Week 2 (r = .35
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ae58ac25b21ed7324a7ba3feb878237b
https://pubmed.ncbi.nlm.nih.gov/2298705
https://pubmed.ncbi.nlm.nih.gov/2298705
Publikováno v:
Journal of clinical psychopharmacology. 8(1)
High potency neuroleptics have been advocated for acute mania because their side effect profile may allow for a more rapid dose escalation and symptom resolution. Low potency neuroleptics have also been advocated because their sedative properties mig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b9ddddddf7390b7959d0dc330164ae6c
https://pubmed.ncbi.nlm.nih.gov/3280617
https://pubmed.ncbi.nlm.nih.gov/3280617
Autor:
Philip G. Janicak, Joseph E. Comaty, C. Malinick, D. B. Bresnahan, Rajiv P. Sharma, J. M. Davis
Publikováno v:
Journal of Clinical Psychopharmacology. 8:33
High potency neuroleptics have been advocated for acute mania because their side effect profile may allow for a more rapid dose escalation and symptom resolution. Low potency neuroleptics have also been advocated because their sedative properties mig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c762725fba668d76e2f33202fc097f35
https://doi.org/10.1097/00004714-198802000-00006
https://doi.org/10.1097/00004714-198802000-00006